Healthcare

in committee · United States · Senate Mar 11, 2025

S 932: Give Kids a Chance Act of 2025

The Give Kids a Chance Act of 2025 modifies FDA regulations to improve pediatric cancer drug development and extends incentives for rare pediatric disease treatments. It requires drug developers seeking approval for molecularly targeted cancer drugs to include pediatric-focused studies (e.g., dosing, safety) for specific cancer types, with new FDA guidance due within 12 months. The bill also extends the rare pediatric disease priority review voucher program through 2029 and mandates a GAO study to evaluate how effectively these vouchers spur development of treatments for rare pediatric diseases, reporting findings by 2034. This directly affects pharmaceutical companies developing cancer drugs and the FDA’s approval process, aiming to accelerate treatments for children with cancer and rare diseases.

Topics ✓ HealthcareSupports HealthcareRequires pediatric-focused drug studies, extends rare disease treatment incentives, and mandates FDA guidance to improve pediatric cancer treatments.95% confidence

Sub-Topics Children's Health

Track

in committee · United States · House Nov 18, 2025

HR 6113: To amend title XVIII of the Social Security Act to impose limitations on contracts with Medicare Advantage organizations offering multiple Medicare Advantage plans under the Medicare program.

This bill limits how many Medicare Advantage (MA) plans a single organization can offer under Medicare contracts. It prohibits the Medicare program from contracting with an MA organization for more than three plans in a single year, and requires that if an organization offers multiple plans, each must be meaningfully different in premiums, benefits, or out-of-pocket costs. The rule applies to new or renewed contracts starting one year after the bill becomes law. It directly affects MA plan providers and Medicare's contracting process, aiming to reduce plan complexity for beneficiaries.

Topics ✗ HealthcareOpposes HealthcareBill restricts Medicare Advantage organizations to max 3 plans with meaningful differences, limiting market options under healthcare program per explicit contract limitations.90% confidence

Sub-Topics Medicare

Track

in committee · United States · House Jul 15, 2025

HR 4407: National Nursing Workforce Center Act of 2025

This bill establishes a 2-year pilot program to create or strengthen state-based nursing workforce centers, funded with $1.5 million annually for 2026-2027. It requires states to match federal funds at a 1:4 ratio (e.g., $1 state funding for every $4 federal) and directs centers to analyze nursing data, address shortages, and develop retention strategies for nurses across all practice settings. Centers must report annually on initiatives like workforce planning, scholarship programs, and efforts to improve rural recruitment, with the goal of reducing nursing shortages and improving geographic distribution. The program targets state agencies, nursing boards, schools of nursing, and community organizations working directly with nursing workforce data and education.

Topics ✓ HealthcareSupports HealthcareBill funds nursing workforce centers to address shortages and improve retention, directly strengthening healthcare delivery through workforce development.95% confidence ✓ Labor & EmploymentSupports Labor & EmploymentEstablishes nursing workforce centers to address shortages, develop retention strategies, and fund scholarship programs - directly advancing nurse employment stability and workforce development within labor policy.90% confidence

Sub-Topics Healthcare Workforce

Track

in committee · United States · House Mar 10, 2025

HR 2002: MATCH IT Act of 2025

The MATCH IT Act of 2025 establishes national standards to improve patient matching accuracy in healthcare, directly affecting hospitals, clinics, health IT vendors, and federal agencies like CMS and HHS. It requires the Secretary of Health and Human Services to develop a uniform definition for measuring patient match rates within 180 days, accounting for duplicate records, overlaid records, and mismatch rates. The bill mandates health IT vendors to incorporate a standardized data set into their systems to support 99.9% matching accuracy, with Medicare providers earning voluntary bonus payments for achieving at least 90% matching accuracy through anonymous reporting. This aims to reduce medical errors, prevent unnecessary tests, and cut costs linked to patient misidentification, which currently cost the healthcare system over $6.7 billion annually.

Topics ✓ HealthcareSupports HealthcareBill establishes national standards for patient matching accuracy in healthcare IT, improving system reliability and reducing errors, directly supporting health services delivery.85% confidence

Sub-Topics Medicaid Medicare

Track

in committee · United States · House Nov 21, 2025

HR 6288: Caring for Grieving Families Act of 2025

This bill requires health plans and insurance to cover prenatal services (like ultrasounds and doctor visits) without additional out-of-pocket costs if a miscarriage or stillbirth occurs before a birth-related bundled payment is made. It directly affects families who experience pregnancy loss, preventing them from being charged extra deductibles, copays, or coinsurance for prenatal care received prior to the loss. The key provision states that cost-sharing for these prenatal services cannot exceed what would have applied if the birth had occurred normally. The rule applies to plans covering bundled birth payments and takes effect for plan years starting January 1, 2027.

Topics ✓ HealthcareSupports HealthcareRequires insurance coverage of prenatal services without cost-sharing for pregnancy loss, expanding access to essential care and protecting patient rights during grief.95% confidence

Sub-Topics Women's Health

Track

in committee · United States · Senate Nov 6, 2025

S 3134: Combating Counterfeit Pharmaceuticals Act of 2025

This bill defines "copy-cat ingredients" as substances mimicking approved drugs but made via different processes or with lower quality, and clarifies "counterfeit drugs" under existing law. It updates the Fentanyl Sanctions Act to replace all references to "opioid" with "illicit drug," expanding the law's scope to cover all counterfeit pharmaceuticals - not just opioid-related products. The bill also adds a waiver allowing access to medications on the HHS drug shortage list. These changes help regulators and law enforcement better identify and address counterfeit drugs affecting patients and the healthcare system.

Topics ✗ Criminal JusticeOpposes Criminal JusticeBill expands drug enforcement scope to all counterfeit pharmaceuticals, increasing criminalization under Fentanyl Sanctions Act90% confidence ✓ HealthcareSupports HealthcareBill combats counterfeit drugs and adds waiver for drug shortages, improving patient safety and access to medications.90% confidence

Sub-Topics Drug Policy Law Enforcement Substance Abuse

Track

in committee · United States · House Mar 21, 2025

HRES 239: Raising awareness of the racial disparities in the impact of colorectal cancer on the Black community.

HRES 239 is a non-binding resolution recognizing racial disparities in colorectal cancer (CRC) outcomes, specifically highlighting that Black Americans face 20% higher CRC rates and 40% higher death rates compared to non-Hispanic Whites. It directly affects Black communities disproportionately impacted by these disparities, which include the lowest 5-year survival rate for CRC. The resolution encourages the CDC to research screening disparities and develop strategies to eliminate them, promotes adherence to U.S. Preventive Services Task Force screening guidelines, and urges states to expand coverage for early CRC screenings, particularly for Black individuals and other high-risk groups. It does not create new laws but aims to raise awareness and guide existing public health efforts.

Topics ✓ HealthcareSupports HealthcareEncourages CDC research on colorectal cancer disparities to improve public health outcomes, directly addressing racial inequities in healthcare access and treatment.85% confidence

Sub-Topics Public Health

Track

in committee · United States · Senate Apr 30, 2025

S 1535: Rural Patient Monitoring (RPM) Access Act

This bill increases Medicare reimbursement rates for rural remote patient monitoring (RPM) services by setting a minimum floor of 1.00 for practice expense and malpractice indices starting in 2026, directly benefiting rural clinics and providers in areas with health care shortages. It requires RPM providers to respond to data anomalies, share patient vitals with electronic health records, and report data to track Medicare savings. The bill mandates a two-year report analyzing cost savings from reduced hospital stays and better medication adherence among beneficiaries using RPM. These changes specifically target improving access to RPM for rural Medicare patients with chronic conditions like heart failure and diabetes.

Topics ✓ HealthcareSupports HealthcareIncreases Medicare RPM reimbursement for rural clinics in healthcare shortage areas, directly improving access and funding for underserved patient monitoring services.95% confidence

Sub-Topics Hospitals Medicare Telehealth Tags Rural Communities

Track

in committee · United States · House Jun 25, 2025

HR 4139: Cutting Copays Act

HR 4139, the Cutting Copays Act, lowers out-of-pocket prescription drug costs for low-income Medicare Part D beneficiaries. It reduces the maximum copay for generic drugs to $0 starting in 2026 and caps copays for other drugs at $3 before 2026, with future adjustments tied to inflation. The bill directly affects Medicare Part D enrollees who qualify for low-income subsidies, ensuring their annual drug costs stay below set limits. These changes modify existing Medicare Part D cost-sharing rules without creating new programs or altering eligibility.

Topics ✓ HealthcareSupports HealthcareBill reduces Medicare Part D copays for low-income beneficiaries, directly improving drug affordability and access - key support indicators for healthcare coverage.95% confidence

Sub-Topics Medicare Prescription Drugs

Track

in committee · United States · Senate Jul 17, 2025

S 2345: Short on Competition Act

The Short on Competition Act creates a new process to address prescription drug shortages by allowing temporary imports of certain drugs. It permits the Secretary of Health and Human Services to authorize imports of drugs with the same active ingredient as a shortage drug, provided they are legally marketed in specific foreign countries and manufacturers commit to seeking U.S. approval. The bill also defines a "marginally competitive market" (fewer than five available drugs for two months, the drug approved over 10 years ago, and all patents expired) as triggering the importation process. Additionally, it requires annual reporting on the number of drugs approved for temporary importation.

Topics ✓ HealthcareSupports HealthcareAddresses prescription drug shortages via temporary imports, improving patient access to essential medications during shortages.85% confidence

Sub-Topics Prescription Drugs

Track